Literature DB >> 32697481

Development of Persistent Respiratory Morbidity in Previously Healthy Children After Acute Respiratory Failure.

Garrett Keim1, Nadir Yehya1, Debbie Spear2, Mark W Hall3, Laura L Loftis4, Jeffrey A Alten5,6, Jennifer McArthur7,8, Pallavi P Patwari9, Robert J Freishtat10,11,12, Douglas F Willson11, John P Straumanis11,13, Neal J Thomas2.   

Abstract

OBJECTIVES: Acute respiratory failure is a common reason for admission to PICUs. Short- and long-term effects on pulmonary health in previously healthy children after acute respiratory failure requiring mechanical ventilation are unknown. The aim was to determine if clinical course or characteristics of mechanical ventilation predict persistent respiratory morbidity at follow-up.
DESIGN: Prospective cohort study with follow-up questionnaires at 6 and 12 months.
SETTING: Ten U.S. PICUs. PATIENTS: Two-hundred fifty-five children were included in analysis after exclusion for underlying chronic disease or incomplete data. One-hundred fifty-eight and 130 children had follow-up data at 6 and 12 months, respectively.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Pulmonary dysfunction at discharge a priori defined as one of: mechanical ventilation, supplemental oxygen, bronchodilators or steroids at 28 days or discharge. Persistent respiratory morbidity a priori defined as a respiratory PedsQL, a pediatric quality of life measure, greater than or equal to 5 or asthma diagnosis, bronchodilator or inhaled steroids, or unscheduled clinical evaluation for respiratory symptoms. Multivariate backward stepwise regression using Akaike information criterion minimization determined independent predictors of these outcomes. Pulmonary dysfunction at discharge was present in 34% of patients. Positive bacterial respiratory culture predicted pulmonary dysfunction at discharge (odds ratio, 4.38; 95% CI, 1.66-11.56). At 6- and 12-month follow-up 42% and 44% of responders, respectively, had persistent respiratory morbidity. Pulmonary dysfunction at discharge was associated with persistent respiratory morbidity at 6 months, and persistent respiratory morbidity at 6 months was strongly predictive of 12-month persistent respiratory morbidity (odds ratio, 18.58; 95% CI, 6.68-52.67). Positive bacterial respiratory culture remained predictive of persistent respiratory morbidity in patients at both follow-up points.
CONCLUSIONS: Persistent respiratory morbidity develops in up to potentially 44% of previously healthy children less than or equal to 24 months old at follow-up after acute respiratory failure requiring mechanical ventilation. This is the first study, to our knowledge, to suggest a prevalence of persistent respiratory morbidity and the association between positive bacterial respiratory culture and pulmonary morbidity in a population of only previously healthy children with acute respiratory failure.

Entities:  

Mesh:

Year:  2020        PMID: 32697481      PMCID: PMC7490803          DOI: 10.1097/CCM.0000000000004380

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   9.296


  29 in total

1.  Reliability, validity, and responsiveness of the pediatric quality of life inventory (PedsQL) generic core scales and asthma symptoms scale in vulnerable children with asthma.

Authors:  Michael Seid; Christine A Limbers; Kimberly A Driscoll; Lisa A Opipari-Arrigan; Leticia Reyes Gelhard; James W Varni
Journal:  J Asthma       Date:  2010-03       Impact factor: 2.515

2.  Respiratory problems 2 years after acute bronchiolitis in infancy.

Authors:  R L Henry; I G Hodges; A D Milner; G M Stokes
Journal:  Arch Dis Child       Date:  1983-09       Impact factor: 3.791

3.  The functional outcome and quality of life of children after admission to an intensive care unit.

Authors:  Anna Taylor; Warwick Butt; Melissa Ciardulli
Journal:  Intensive Care Med       Date:  2003-02-21       Impact factor: 17.440

Review 4.  A prospective assessment of diagnostic efficacy of blind protective bronchial brushings compared to bronchoscope-assisted lavage, bronchoscope-directed brushings, and blind endotracheal aspirates in ventilator-associated pneumonia.

Authors:  Andrea Y Wood; Alexander J Davit; David L Ciraulo; Nathan W Arp; Charles M Richart; Robert A Maxwell; Donald E Barker
Journal:  J Trauma       Date:  2003-11

Review 5.  Functional Outcomes and Physical Impairments in Pediatric Critical Care Survivors: A Scoping Review.

Authors:  Chengsi Ong; Jan Hau Lee; Melvin K S Leow; Zudin A Puthucheary
Journal:  Pediatr Crit Care Med       Date:  2016-05       Impact factor: 3.624

6.  Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study.

Authors:  Robinder G Khemani; Lincoln Smith; Yolanda M Lopez-Fernandez; Jeni Kwok; Rica Morzov; Margaret J Klein; Nadir Yehya; Douglas Willson; Martin C J Kneyber; Jon Lillie; Analia Fernandez; Christopher J L Newth; Philippe Jouvet; Neal J Thomas
Journal:  Lancet Respir Med       Date:  2018-10-22       Impact factor: 30.700

7.  Assessing health outcomes, quality of life, and healthcare use among school-age children with asthma.

Authors:  Matthew J Lozier; Hatice S Zahran; Cathy M Bailey
Journal:  J Asthma       Date:  2018-02-09       Impact factor: 2.515

Review 8.  Development of the lung.

Authors:  Johannes C Schittny
Journal:  Cell Tissue Res       Date:  2017-01-31       Impact factor: 5.249

Review 9.  The Economic Burden of Pediatric Asthma in the United States: Literature Review of Current Evidence.

Authors:  Richard Perry; George Braileanu; Thomas Palmer; Paul Stevens
Journal:  Pharmacoeconomics       Date:  2019-02       Impact factor: 4.981

Review 10.  Understanding alveolarization to induce lung regeneration.

Authors:  José Alberto Rodríguez-Castillo; David Bravo Pérez; Aglaia Ntokou; Werner Seeger; Rory E Morty; Katrin Ahlbrecht
Journal:  Respir Res       Date:  2018-08-06
View more
  7 in total

1.  Inhaled Nitric Oxide Use and Outcomes in Critically Ill Children With a History of Prematurity.

Authors:  Aline B Maddux; Peter M Mourani; Russell Banks; Ron W Reeder; Murray M Pollack; Robert A Berg; Kathleen L Meert; Patrick S McQuillen; Andrew R Yates; Daniel A Notterman; John T Berger
Journal:  Respir Care       Date:  2021-10       Impact factor: 2.339

2.  Association of Acute Respiratory Failure in Early Childhood With Long-term Neurocognitive Outcomes.

Authors:  R Scott Watson; Sue R Beers; Lisa A Asaro; Cheryl Burns; Min Jung Koh; Mallory A Perry; Derek C Angus; David Wypij; Martha A Q Curley
Journal:  JAMA       Date:  2022-03-01       Impact factor: 157.335

3.  Postdischarge health resource use in pediatric survivors of prolonged mechanical ventilation for acute respiratory illness.

Authors:  Michelle Vo; Kristen Miller; Tellen D Bennett; Peter M Mourani; Jaime LaVelle; Todd C Carpenter; R Scott Watson; Laura L Pyle; Aline B Maddux
Journal:  Pediatr Pulmonol       Date:  2022-04-26

4.  The authors reply.

Authors:  Garrett Keim; Nadir Yehya; Neal J Thomas
Journal:  Crit Care Med       Date:  2020-12       Impact factor: 9.296

5.  SNP-SNP Interactions of Surfactant Protein Genes in Persistent Respiratory Morbidity Susceptibility in Previously Healthy Children.

Authors:  Chintan K Gandhi; Neal J Thomas; Ye Meixia; Debbie Spear; Chenqi Fu; Shouhao Zhou; Rongling Wu; Garrett Keim; Nadir Yehya; Joanna Floros
Journal:  Front Genet       Date:  2022-03-24       Impact factor: 4.599

Review 6.  Mechanical Ventilation in Pediatric and Neonatal Patients.

Authors:  Michaela Kollisch-Singule; Harry Ramcharran; Joshua Satalin; Sarah Blair; Louis A Gatto; Penny L Andrews; Nader M Habashi; Gary F Nieman; Adel Bougatef
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

7.  Inflammatory Biomarkers Are Associated With a Decline in Functional Status at Discharge in Children With Acute Respiratory Failure: An Exploratory Analysis.

Authors:  Erin F Carlton; Heidi M Weeks; Mary K Dahmer; Michael W Quasney; Anil Sapru; Martha A Q Curley; Heidi R Flori
Journal:  Crit Care Explor       Date:  2021-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.